ClinVar Miner

Submissions for variant NM_000492.4(CFTR):c.1040G>T (p.Arg347Leu)

dbSNP: rs77932196
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 7
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Baylor Genetics RCV001004252 SCV001163128 likely pathogenic Cystic fibrosis; Congenital bilateral aplasia of vas deferens from CFTR mutation criteria provided, single submitter clinical testing
CFTR-France RCV000007591 SCV001169459 pathogenic Cystic fibrosis 2018-01-29 criteria provided, single submitter curation
Labcorp Genetics (formerly Invitae), Labcorp RCV000007591 SCV002129541 pathogenic Cystic fibrosis 2024-01-21 criteria provided, single submitter clinical testing This sequence change replaces arginine, which is basic and polar, with leucine, which is neutral and non-polar, at codon 347 of the CFTR protein (p.Arg347Leu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with cystic fibrosis or congenital bilateral absence of the vas deferens (PMID: 10923036). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 7171). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CFTR protein function with a positive predictive value of 80%. This variant disrupts the p.Arg347 amino acid residue in CFTR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 2344617, 12400067, 21679131, 22020151, 25583415). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic.
Institute of Human Genetics, University of Leipzig Medical Center RCV000007591 SCV002574019 pathogenic Cystic fibrosis 2022-09-05 criteria provided, single submitter curation This variant was identified in 1 patient with a clinically confirmed diagnosis of cystic fibrosis. The variant was classified in the context of a project re-classifying variants in the German Cystic Fibrosis Registry (Muko.e.V.). Link: https://www.muko.info/angebote/qualitaetsmanagement/register/cf-einrichtungen/mukoweb. Criteria applied: PS3_SUP, PM3, PM2_SUP, PM5_STR, PP3, PP4
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV000007591 SCV004039143 pathogenic Cystic fibrosis 2023-08-14 criteria provided, single submitter clinical testing Variant summary: CFTR c.1040G>T (p.Arg347Leu) results in a non-conservative amino acid change located in the ABC transporter type 1, transmembrane domain (IPR011527) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251126 control chromosomes (gnomAD). c.1040G>T has been reported in the literature in individuals affected with Cystic Fibrosis (examples: Stratton_2012, Hu_2017, Clausters_2000). These data indicate that the variant is likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 29095814, 10923036, 22787562). Other variants affecting the same codon have been classified pathogenic in ClinVar and internally (CV ID 7182, 7110). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic.
Baylor Genetics RCV003466829 SCV004215787 likely pathogenic Bronchiectasis with or without elevated sweat chloride 1 2022-03-14 criteria provided, single submitter clinical testing
OMIM RCV000007591 SCV000027792 pathogenic Cystic fibrosis 2018-04-09 no assertion criteria provided literature only

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.